JSSH
MRNA icon

J. Safra Sarasin Holding’s Moderna MRNA Stock Holding History

J. Safra Sarasin Holding’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
+5,841
New +$302K 0.01% 582
2024
Q3 		– Sell
-6,805
Closed -$808K – 466
2024
Q2 		$808K Buy
+6,805
New +$861K 0.01% 365

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

J. Safra Sarasin Holding's MRNA Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in Moderna (MRNA) in Q2 2026: 5,841 shares worth $409K. The stake represents 0.01% of the portfolio and ranks #582 among its holdings. This is a return to the name: J. Safra Sarasin Holding previously reported a position in MRNA as recently as Q2 2024.

J. Safra Sarasin Holding first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. The position peaked at $808K in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • J. Safra Sarasin Holding held 5,841 shares of Moderna worth $409K as of Q2 2026.
  • Moderna was a new J. Safra Sarasin Holding position in Q2 2026.
  • Moderna made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #582 holding.
  • J. Safra Sarasin Holding first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
  • J. Safra Sarasin Holding's Moderna position peaked at $808K in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.